You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,199 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Melanoma
  • 89Zirconium-labeled ipilimumab
  • Amsterdam, Noord-Holland, Netherlands
    VU Medical Center
2021-04-14
Apr 14, 2021
H
Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
2022-01-19
Jan 19, 2022
G
Active, not recruiting
  • Stage III/IV Melanoma
  • Ipilimumab IT
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
2021-07-21
Jul 21, 2021
S
Active, not recruiting
  • Neuroendocrine Tumors
  • Carcinoid Tumor
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
2021-12-15
Dec 15, 2021
D
Active, not recruiting
  • Thyroid Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-02-18
Feb 18, 2022
U
Active, not recruiting
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
2021-09-27
Sep 27, 2021
L
Terminated
  • Prostatic Neoplasms
  • PROSTVAC V/F
  • Ipilimumab
  • San Francisco, California
    University of California, San Francisco
2021-10-25
Oct 25, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Washington, District of Columbia
  • +1 more
2022-01-10
Jan 10, 2022
M
Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-12
Jan 12, 2022
N
Active, not recruiting
  • Metastatic Leiomyosarcoma
  • +2 more
  • Ipilimumab
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-10-01
Oct 1, 2021
U
Recruiting
  • Prostate Cancer
  • Nivolumab & Ipilimumab
  • London, United Kingdom
    University College London Hospital
2022-01-06
Jan 6, 2022
K
Active, not recruiting
  • Soft Tissue Sarcoma
  • Ipilimumab
  • +2 more
  • Stanford, California
    Stanford Medical Center
2022-02-02
Feb 2, 2022
D
Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
2022-02-15
Feb 15, 2022
N
Active, not recruiting
  • Melanoma
  • Nivolumab
  • Ipilimumab
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center
2022-01-18
Jan 18, 2022
P
Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Intratumoral Ipilimumab
  • Portland, Oregon
    Portland Providence Medical Center
2022-01-31
Jan 31, 2022
D
Active, not recruiting
  • Head and Neck Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-02-22
Feb 22, 2022
R
Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Ipilimumab
  • Nivolumab
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
2021-11-16
Nov 16, 2021
N
Recruiting
  • Metastatic Solid Tumors
  • Treatment-Refractory Cancers
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
S
Recruiting
  • Basal Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins Hospital
2022-03-10
Mar 10, 2022
M
Active, not recruiting
  • Advanced Cancers
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-11
Feb 11, 2022
P
Recruiting
  • Kidney Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-03-22
Mar 22, 2022
D
Recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-11-10
Nov 10, 2021
M
Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-11
Feb 11, 2022
U
Completed
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
H
Active, not recruiting
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021